5 Biotech Stocks to Sell Now According to Cathie Wood

4. Caribou Biosciences, Inc. (NASDAQ:CRBU)

Number of Hedge Fund Holders: 24    

Percentage Decrease in Stake in Q4: 100%  

Caribou Biosciences, Inc. (NASDAQ:CRBU) is a clinical stage biopharma firm that develops treatments for solid tumors. Wood had first purchased a stake in the company during the third quarter of 2021, buying nearly 5,000 shares at an average price of $24.45 per share. She sold off that entire stake in the next quarter. 

Other hedge funds have also been selling Caribou Biosciences, Inc. (NASDAQ:CRBU) stock. At the end of the fourth quarter of 2021, 24 hedge funds in the database of Insider Monkey held stakes worth $233 million in Caribou Biosciences, Inc. (NASDAQ:CRBU), compared to 26 the preceding quarter worth $297 million.